Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7a pseudogene 46 (RPL7AP46) is a processed pseudogene found in the human genome. It is derived from the *RPL7A* gene, which encodes a component of the large 60S ribosomal subunit, but RPL7AP46 itself is noncoding and not translated into a functional protein[4]. Pseudogenes like RPL7AP46 are common and arise from gene duplication or retrotransposition events, but they are generally inactive and do not participate in cellular functions, signaling, or disease processes[4]. RPL7AP46 should not be considered a therapeutic target; instead, it is an inactive genomic sequence without known biological or biomedical relevance. If you are seeking information on drug targets, receptors, or biologically active proteins, RPL7AP46 is not appropriate. For clinically relevant information, refer to the functional gene encoding ribosomal protein L7a (RPL7A)[1][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 46 (RPL7AP46).